SMTL ID : 4bcq.1 (1 other biounit)

Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-oligomer

Ligands

1 x TJF: 4-[4-METHYL-2-(METHYLAMINO)-1,3-THIAZOL-5-YL]-2-{[3-(MORPHOLIN-4-YLCARBONYL)PHENYL]AMINO}PYRIMIDINE-5-CARBONITRILE(Non-covalent)

TJF.1: 12 residues within 4Å: Chain A: I.13, V.21, V.67, F.83, E.84, F.85, L.86, H.87, K.92, N.135, L.137, D.148 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.13, A:I.13, A:V.21, A:F.85, A:L.137 Hydrogen bonds: A:L.86, A:L.86, A:D.148

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hole, A.J. et al., Comparative Structural and Functional Studies of 4-(Thiazol- 5-Yl)-2-(Phenylamino)Pyrimidine-5-Carbonitrile Cdk9 Inhibitors Suggest the Basis for Isotype Selectivity. J.Med.Chem. (2013)

Release Date

2013-01-09

Peptides

CYCLIN-DEPENDENT KINASE 2: A
CYCLIN-A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

CYCLIN-DEPENDENT KINASE 2

CYCLIN-A2

Related Entries With Identical Sequence